These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34576030)

  • 41. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
    Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
    N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonal Hematopoiesis Is Associated With Long-Term Adverse Outcomes Following Cardiac Surgery.
    Ninni S; Vicario R; Coisne A; Woitrain E; Tazibet A; Stewart CM; Diaz LA; White JR; Koussa M; Dubrulle H; Juthier F; Jungling M; Vincentelli A; Edme JL; Nattel S; de Winther M; Geissmann F; Dombrowicz D; Staels B; Montaigne D
    J Am Heart Assoc; 2024 Sep; 13(17):e034255. PubMed ID: 39206728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans.
    Kaasinen E; Kuismin O; Rajamäki K; Ristolainen H; Aavikko M; Kondelin J; Saarinen S; Berta DG; Katainen R; Hirvonen EAM; Karhu A; Taira A; Tanskanen T; Alkodsi A; Taipale M; Morgunova E; Franssila K; Lehtonen R; Mäkinen M; Aittomäki K; Palotie A; Kurki MI; Pietiläinen O; Hilpert M; Saarentaus E; Niinimäki J; Junttila J; Kaikkonen K; Vahteristo P; Skoda RC; Seppänen MRJ; Eklund KK; Taipale J; Kilpivaara O; Aaltonen LA
    Nat Commun; 2019 Mar; 10(1):1252. PubMed ID: 30890702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural history of clonal haematopoiesis seen in real-world haematology settings.
    Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
    Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer.
    Zuriaga MA; Fuster JJ
    Clin Investig Arterioscler; 2023; 35(1):35-41. PubMed ID: 34879980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-Associated
    Ferrone CK; Blydt-Hansen M; Rauh MJ
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
    Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT
    JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal hematopoiesis and vascular disease.
    Amancherla K; Wells JA; Bick AG
    Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CHIPing away at immunity: the role of clonal hematopoiesis of indeterminate potential in bacterial pneumonia.
    Bou Ghanem EN
    J Clin Invest; 2024 Jun; 134(11):. PubMed ID: 38828722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
    Burns SS; Kapur R
    Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease.
    Hecker JS; Hartmann L; Rivière J; Buck MC; van der Garde M; Rothenberg-Thurley M; Fischer L; Winter S; Ksienzyk B; Ziemann F; Solovey M; Rauner M; Tsourdi E; Sockel K; Schneider M; Kubasch AS; Nolde M; Hausmann D; Paulus AC; Lützner J; Roth A; Bassermann F; Spiekermann K; Marr C; Hofbauer LC; Platzbecker U; Metzeler KH; Götze KS
    Blood; 2021 Nov; 138(18):1727-1732. PubMed ID: 34139005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
    Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss.
    Wang H; Divaris K; Pan B; Li X; Lim JH; Saha G; Barovic M; Giannakou D; Korostoff JM; Bing Y; Sen S; Moss K; Wu D; Beck JD; Ballantyne CM; Natarajan P; North KE; Netea MG; Chavakis T; Hajishengallis G
    Cell; 2024 Jul; 187(14):3690-3711.e19. PubMed ID: 38838669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
    Bick AG; Pirruccello JP; Griffin GK; Gupta N; Gabriel S; Saleheen D; Libby P; Kathiresan S; Natarajan P
    Circulation; 2020 Jan; 141(2):124-131. PubMed ID: 31707836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Telomeres as Therapeutic Targets in Heart Disease.
    Yeh JK; Lin MH; Wang CY
    JACC Basic Transl Sci; 2019 Nov; 4(7):855-865. PubMed ID: 31998853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis　- Beyond Conventional Cardiovascular Risk Factors.
    Zuriaga MA; Fuster JJ
    Circ J; 2023 Feb; 87(3):394-400. PubMed ID: 34433749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TET2 mutation as prototypic clonal hematopoiesis lesion.
    Guarnera L; Jha BK
    Semin Hematol; 2024 Feb; 61(1):51-60. PubMed ID: 38431463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.